⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | HDFC Multi Cap Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | HDFC MF | HDFC MF |
| Category | Equity - Multi Cap Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹18.50 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★ | ★★★★★ |
| Benchmark | Nifty500 Multicap 50:25:25 - TRI | BSE Health Care - TRI |
| Fund Manager | Amar Kalkundrikar | Nikhil Mathur |
| Inception | 10 Dec 2021 | 04 Oct 2023 |
| Returns | ||
| 1Y | -9.25% | 22.64% |
| 3Y | 10.52% | 30.41% |
| 5Y | — | — |
| Since Inception | 13.48% | 29.15% |
| Risk | ||
| 15.23 | 14.07 | |
| 1.01 | 0.59 | |
| 0.33 | 1.59 | |
| -0.34 | 21.67 | |
| 0.61 | 3.48 | |
| -11.67% | -9.23% | |
| Costs | ||
| Expense Ratio | 0.94% | 1.03% |
| Exit Load | 1% on or before 1Y, Nil after 1Y | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹100 | ₹100 |
| Min Lumpsum | ₹100 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
HDFC MF97%
HDFC MF97%
2.7%Only 2.7% of holdings by weight are common between HDFC MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingHDFC MFHDFC MF
TREPS - Tri-party Repo1.49%4.67%
Alkem Laboratories Ltd.1.19%4.64%
Category context: Equity vs Equity. Open the full Screener →